The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Myopia and Presbyopia Treatment Market Progress Between 2026 And 2030?
The myopia and presbyopia treatment market size has experienced robust expansion in recent years. It is anticipated to increase from $22.63 billion in 2025 to $24.56 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.6%. The historical growth of this market was primarily driven by factors such as an increase in the aging population, widespread adoption of corrective lenses, a rise in screen-induced myopia, early developments in refractive surgery, and limited awareness regarding preventive eye care.
The myopia and presbyopia treatment market is projected to experience substantial expansion over the upcoming years, with its size anticipated to reach $33.57 billion by 2030, exhibiting an impressive compound annual growth rate (CAGR) of 8.1%. This projected growth throughout the forecast period stems from several factors, including the escalating demand for sophisticated surgical remedies, the rising uptake of lenses designed to correct presbyopia, the increased application of pharmacological interventions, advancements in eye care diagnostic technologies, and the broadening reach of preventive screening initiatives. Furthermore, key trends anticipated in this period encompass the growing popularity of multifocal and advanced contact lenses, an increasing call for laser and refractive surgical operations, a stronger inclination towards orthokeratology (ortho-k) for myopia management, greater deployment of pharmacological eye drops to address presbyopia, and the widening scope of early vision screening and preventive care programs.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7892&type=smp
What Key Drivers Are Fueling The Growth Of The Myopia and Presbyopia Treatment Market?
The anticipated increase in vision impairment cases is projected to propel the expansion of the myopia and presbyopia treatment market. Vision impairment describes a state where an individual’s capacity to see and process visual data is considerably diminished, causing challenges in recognizing and comprehending their surroundings. This escalating prevalence of vision impairment can stimulate the advancement of myopia and presbyopia treatments, fostering greater awareness, driving innovation, attracting investments, enhancing treatment accessibility, and ultimately yielding improved results for individuals addressing their vision problems. For instance, in August 2023, according to the World Health Organization (WHO), a Switzerland-based United Nations agency, global estimates indicate that 2.2 billion people have near or distance vision impairment, including 1 billion cases that are preventable or untreated, while refractive errors and cataracts remain the leading global causes of vision loss, and only 36% of individuals with refractive-error–related distance impairment and just 17% of those with cataract-related impairment have received appropriate care. Consequently, the increasing occurrence of vision impairment is a key factor fueling the growth of the myopia and presbyopia treatment market.
Which Segment Classifications Are Used In The Myopia and Presbyopia Treatment Market Segment Analysis?
The myopia and presbyopia treatment market covered in this report is segmented –
1) By Type: Myopia, Presbyopia
2) By Age Group: Children And Young Adults, Adults, Geriatrics
3) By End-Use: Hospitals, Eye Care Clinics Or Ophthalmic Centers
Subsegments:
1) By Myopia: Pharmacological Treatments, Orthokeratology Lenses, Refractive Surgery, Spectacles And Contact Lenses
2) By Presbyopia: Multifocal Lenses, Monovision Contact Lenses, Corneal Inlays, Presbyopia-Correcting Surgery
What Trends Are Influencing The Myopia and Presbyopia Treatment Market?
Leading companies in the myopia and presbyopia treatment market are actively developing innovative products, such as myopia-combating sun spectacle lenses, to reach broader customer bases, increase sales, and boost revenue. Myopia-combating sun spectacle lenses are defined as eyeglass lenses designed to help slow the progression of myopia, also known as near-sightedness, when worn in outdoor or bright sunlight conditions. For example, in May 2023, HOYA, an optical technology company based in Thailand, introduced MiYOSMART sun spectacle lenses specifically to address myopia in children. The unique characteristic of MiYOSMART lies in its novel strategy for slowing down myopia progression in children while simultaneously offering protection from intense sunlight. This is achieved through two specialized lens options: the photochromic spectacle lenses, MiYOSMART Chameleon, and the polarized spectacle lenses, MiYOSMART Sunbird, both of which integrate DIMS Technology (Defocus Incorporated Multiple Segments). DIMS Technology, developed in partnership with the Hong Kong Polytechnic University, operates on the principle of generating simultaneous defocus during both distance and near viewing. This involves establishing one plane on the retina from the lens’s single vision zone(s) and creating another plane of myopic defocus using +3.50D defocus lenslets.
Which Firms Are Contributing To The Myopia and Presbyopia Treatment Market Ecosystem?
Major companies operating in the myopia and presbyopia treatment market are ALCON Inc., Bausch & Lomb Incorporated, Carl Zeiss AG, Essilor Ltd., Johnson & Johnson Vision Inc., Nidek Corporation, Topcon Corporation, Zimmer Ophthalmic Systems AG, AbbVie Inc., Orasis Pharmaceuticals Ltd., The Cooper Companies Inc., Staar Surgical Co., Eyenovia Inc., Allergan PLC, Hoya Corporation, Menicon Co. Ltd., CooperVision Inc., Visioneering Technologies Inc., AcuFocus Inc., Ocular Therapeutix Inc., SightGlass Vision Inc., Presbia PLC, LensGen Inc., RxSight Inc., Perfect Lens LLC
Get The Full Myopia and Presbyopia Treatment Market Report:
Which Geographic Region Dominates The Myopia and Presbyopia Treatment Market?
North America was the largest region in the myopia and presbyopia treatment market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myopia and presbyopia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Myopia and Presbyopia Treatment Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Myopia and Presbyopia Treatment Market 2026, By The Business Research Company
Surgical Stapling Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/surgical-stapling-devices-global-market-report
Powered Surgical Instruments Market Report
https://www.thebusinessresearchcompany.com/report/powered-surgical-instruments-global-market-report
Urology Surgical Instruments Market Report
https://www.thebusinessresearchcompany.com/report/urology-surgical-instruments-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model